LIVE vs NBIX · rev $472.8M vs P/E 45, rev $2.36B
Live Ventures Inc (LIVE) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Live Ventures Inc (LIVE) is a home improvement retail company listed on NASDAQ.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported LIVE revenue for 2024-09-30 was $472.8M. Net income was -$26.7M. Revenue was up 33.1% from 2023-09-30 to 2024-09-30. LIVE currently screens at market cap $29.3M.
Latest reported NBIX revenue for 2024-12-31 was $2.36B. Net income was $341.3M. Revenue was up 24.8% from 2023-12-31 to 2024-12-31. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
LIVE currently screens at market cap $29.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the LIVE and NBIX stock pages for the full models.
Not investment advice.